So, they have nonbinding for $350m. Imo for 7 to 1

Quote:

---

So, they have nonbinding for $350m. Imo for 7 to 10 million vials.or $2.5B revenue or $150 share price.

Any objection to.my rough estimates? Ohm, others.?

---

A lot of unknown variables so speculation must be made.

10 million vials @ $200 (1 dose, 2 vials - $400) = $2 billion. 50% split with distributor = $1 billion. $1 billion - $200 million (10% royalties at retail/wholesale) = $800 million. $800 million - $300 million (overheard, distribution and new trials) = $500 million earnings. $500 million x 25 P/E = $12.5 billion market cap. $12.5 billion / 800 million shares = $15.62

Of course the above share price does not reflect the potential from HIV BLA, NASH, longhaulers, cancer and other diseases. Once Cytodyn is known from a Covid EUA FOMO should escalate once investors do due diligence.